To the Editor:—
I should like to bring to your attention an error which, although probably typographical, is misleading, with possible serious consequences. In The Journal (196:651, 1966) is a discussion of "A Nonsteroidal Anti-inflammatory Agent: Indomethacin (Indocin)." At the end of the article under "Generic and Trade Names of Drugs" are listed "Phenylbutazone—Butazolidin." Indomethacin and phenylbutazone are, of course, two separate drugs.The dangers of prescribing phenylbutazone mistakenly when indomethacin is intended are obvious.